Summer 2026
Engineering Co-op
Thermo Fisher Scientific
10,001+ employees
Supplies laboratory instruments, reagents, diagnostics
Compensation Overview
$25.25 - $33.75/hr
No H1B Sponsorship
Hillsboro, OR, USA
In Person
On-site role in Hillsboro, Oregon. Relocation stipend may be available for eligible candidates (50+ miles from location).
Bachelor's
 Software Engineering (1) |
|---|
Get referred to Thermo Fisher Scientific
See people who can refer or advise you
- Undergraduate student completing a Bachelor’s degree in Computer Science.
- 0 years of work experience required; previous related internships preferred.
- Consistent track record of results demonstrating integrity, innovation, involvement, and intensity.
- Energized through championing change, driven in getting results, and savvy in navigating ambiguity.
- Excellent interpersonal communication skills with a high degree of emotional intelligence.
- If this sounds like you, we'd love to hear from you!
- To qualify, applicants must be legally authorized to work in the United States and should not require sponsorship (current or future) for employment visa status. Thermo Fisher does not offer employment in this position to holders of F-1, J-1, H-1, OPT, and CPT Visas for the purpose of obtaining practical experience.
- Develop, characterize, and document workflows and applications that automate small-chamber and wafer-level dual beam microscope functionality.
- Collaborate with team to translate customer needs into workable solutions, help create customer training material.
- Cultivate positive customer relationships.
- Provide continuous feedback to the product groups on system performance, features, and potential challenges.
Thermo Fisher Scientific provides life sciences tools and services for research, healthcare, and industry. Its products include laboratory instruments, reagents, consumables, and software for activities like protein biology, PCR, sequencing, and bioprocessing. It differentiates itself with an end-to-end footprint across trusted brands and strong customer support and education, plus direct sales and promotions. Its goal is to help make the world healthier, cleaner, and safer by enabling discovery, diagnostics, and quality manufacturing across research institutions, healthcare providers, and government bodies.
Company Size
10,001+
Company Stage
IPO
Headquarters
Waltham, Massachusetts
Founded
1956
Get referred to Thermo Fisher Scientific
See people who can refer or advise you
Simplify's Take
What believers are saying
- Thermo Fisher raised 2026 guidance on July 23 after Q2 revenue hit $11.99 billion.
- July 2026 launches included Orbitrap Apex, InstaFlux, and X2/S2 centrifuges.
- August 13, 2026 Vietnam MoU opens shared-lab sales in semiconductors and biomedicine.
What critics are saying
- August 4, 2026 CVE-2026-17583 lets attackers tamper with forensic DNA files.
- Franklin and Massachusetts viral-vector closures cut jobs through late 2026.
- Clario integration and microbiology divestiture expose Thermo Fisher to execution slippage in 2026.
What makes Thermo Fisher Scientific unique
- Thermo Fisher spans instruments, consumables, diagnostics, and services across 50+ countries.
- Its 2026 NVIDIA collaboration fuses lab hardware with AI-enabled instrumentation.
- EXENT, Oncomine, and Orbitrap give Thermo Fisher end-to-end workflow ownership.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Disability Insurance
Unlimited Paid Time Off
Paid Vacation
Paid Sick Leave
Paid Holidays
Hybrid Work Options
401(k) Retirement Plan
401(k) Company Match
Employee Stock Purchase Plan
Fertility Treatment Support
Family Planning Benefits
Professional Development Budget
Conference Attendance Budget
Wellness Program
Mental Health Support
Gym Membership
Phone/Internet Stipend
Home Office Stipend
Company News
NIC and Thermo Fisher advance shared tech infrastructure. The National Innovation Centre (NIC) and Thermo Fisher Scientific held a forum on advancing Vietnam's semiconductor, AI, and innovation ambitions on August 13. The event brought together representatives from government agencies, experts, businesses, research institutes, universities and partners in semiconductors, AI, biomedical technology and innovation to discuss cooperation opportunities, promote shared research infrastructure and strengthen Vietnam's innovation ecosystem. | Photo: NIC | Recognising shared research and technology infrastructure as a key impediment in the development of strategic technology industries, the NIC has stepped up cooperation with Thermo Fisher Scientific, a global technology group specialising in life sciences, research, analytical technologies and solutions for a range of high-tech industries. During his visit to Vietnam, Gianluca Pettiti, president and COO, and president of Life Sciences Solutions at Thermo Fisher Scientific, attended the forum and discussed cooperation potential with the NIC and Vietnamese partners, particularly in developing scientific and technological infrastructure and shared research models. The partnership between NIC and Thermo Fisher aims to bring advanced international infrastructure, equipment, technologies and expertise closer to Vietnamese businesses, startups, research institutes and universities. This is expected to reduce technology access costs, shorten research and product development timelines, and strengthen domestic innovation capacity. Pettiti said, "Vietnam has significant opportunities to develop high-tech industries and needs continued investment in research infrastructure, technology, human resources and stronger links between research and businesses." Thermo Fisher Scientific aims to contribute its technology, equipment and expertise to help Vietnam strengthen research, product development and innovation capabilities. "Connecting the company's technological capabilities, equipment and expertise with Vietnamese government agencies, universities, research institutes and businesses will expand access to advanced technologies, accelerate their application and help bring research outcomes into practice," he added. Speaking at the forum, Vo Xuan Hoai, deputy director of NIC, said, "The greatest value of the cooperation between NIC and Thermo Fisher lies in jointly building an open research infrastructure model where businesses, startups, universities and research institutes can access internationally standardised technologies, equipment and expertise at more reasonable costs and within shorter timeframes." Under the cooperation framework, a shared laboratory at NIC Hoa Lac will serve as foundational infrastructure for research, product development, technology testing and workforce training. NIC will work with Thermo Fisher to develop an implementation roadmap while connecting businesses, startups, research institutes and universities that need access to the infrastructure. The two sides will also promote training and capacity-building programmes and mobilise additional technology corporations, research organisations and international partners to participate. Through the initiative, NIC aims to establish an internationally standardised model of shared research and innovation infrastructure at Hoa Lac High-Tech Park, enabling domestic and international technology resources to be used more effectively and potentially replicated in other strategic technology fields. | MoU signing ceremony between NIC and Thermo Fisher Scientific. Photo: NIC | The forum featured a panel discussion on developing shared infrastructure for semiconductors, AI, and biomedical technology, with the participation of Dan Kritenbrink, former US Ambassador to Vietnam, representatives from Thermo Fisher Scientific, relevant agencies, Hanoi Industrial Park Management Board, Hanoi University of Science and Technology, and Vietnam National University, also in Hanoi. During the forum, NIC and Thermo Fisher Scientific signed a MoU, marking a new step in their cooperation to support Vietnam's innovation ecosystem through shared science and technology infrastructure and stronger public-private cooperation in strategic technology fields. Under the cooperation framework, Thermo Fisher is expected to work with the NIC to develop an internationally standardised shared laboratory for semiconductor and biomedical technologies at NIC Hoa Lac. The infrastructure will serve businesses, startups, research institutes and universities while enabling Vietnamese organisations to access international technologies, equipment and expertise. For the NIC, the MoU represents an initial step towards developing a new public-private cooperation model for technology infrastructure. Under this model, the state will play a role in enabling and connecting resources; international technology companies will contribute technologies and expertise; while businesses, research institutes, and universities will directly utilise the infrastructure, develop technologies, and commercialise research results. Through its cooperation with Thermo Fisher Scientific, the NIC is reinforcing its role as a national hub connecting technology resources, expertise, infrastructure and the domestic market with leading global technology corporations.
XPO appoints Jonas Svedlund as chief legal officer. Greenwich, Conn. - WEBWIRE - Tuesday, August 11, 2026 XPO (NYSE: XPO), a leading provider of freight transportation in North America, announced that Jonas Svedlund has joined the company as chief legal officer, effective immediately. He will lead the company's legal and compliance functions, including corporate governance and commercial matters. Mario Harik, chairman and chief executive officer of XPO, said, "Jonas is an accomplished executive who will help advance our strategic priorities. He brings deep legal expertise and a proven ability to partner with organizational leaders at every level. He is an excellent addition to our leadership team and I'm pleased to welcome him to XPO." Svedlund most recently served as deputy general counsel for Thermo Fisher Scientific, where he oversaw the company's corporate and commercial legal functions. Earlier, he held various executive roles during more than a decade with General Electric, including serving as general counsel for two separate GE businesses. He began his career as a corporate attorney with Sullivan & Cromwell. Svedlund holds a juris doctor degree from Harvard Law School and a bachelor's degree from the University of California, Berkeley. About XPO XPO, Inc. (NYSE: XPO) is a leader in asset-based less-than-truckload (LTL) freight transportation in North America. The company's customer-focused organization efficiently moves 16 billion pounds of freight per year, enabled by its proprietary technology. XPO serves 55,000 customers with 586 locations and 38,000 employees in North America and Europe, and is headquartered in Greenwich, Conn., USA. Visit xpo.com for more information, and connect with XPO on LinkedIn, Facebook, X, Instagram and YouTube. WebWireID358731 This news content was configured by WebWire editorial staff. Linking is permitted. Distribute your news. * Every day, hundreds of individuals and companies choose WebWire to distribute their news. * WebWire places your news within numerous highly trafficked news search engines generating leads and publicity. * Submit Your Release Now!
Thermo Fisher Scientific and Danaher, two major life sciences tools companies, both reported better-than-expected second-quarter results, but their recoveries show different trajectories. Thermo Fisher posted 10% revenue growth to $11.99 billion and 13% adjusted EPS growth to $6.03. The company raised guidance citing broad-based demand improvement across pharmaceutical and biotechnology markets. Its Life Sciences Solutions segment grew 13% year-over-year, whilst Analytical Instruments returned to growth after nearly two years of weak demand. Danaher's recovery remains more uneven, though it achieved high-single-digit adjusted EPS growth with improving core growth versus the previous quarter. Thermo Fisher's recovery appears more broad-based across multiple segments, suggesting greater durability. The company continues investing in product innovation, including new Orbitrap mass spectrometers.
Suit says faith foiled by fossil fuels in 401(k) funds. A new 401(k) suit alleges employment discrimination for refusing to offer investment options that don't invest in fossil fuels. A new 401(k) suit alleges employment discrimination in a refusal to offer investment options that don't invest in fossil fuels. The plaintiff here[i] is Dr. Andrew Hartley, a statistical science director at Thermo Fisher Scientific Inc., and the suit accuses his employer of discriminating against him and refusing to accommodate his religious beliefs in violation of Title VII[ii] and the New York State Human Rights Law. The suit asserts that he is a devout Christian and member of the United Methodist Church, and that he sincerely believes[iii] that investing his retirement money in "ecologically and socially destructive" fossil fuel companies violates his religious beliefs. The suit (Hartley v. Thermo Fisher Scientific Inc., case number 1:26-cv-01612, in the U.S. District Court for the Western District of New York) further asserts that due to the reality that Thermo Fisher's current equity-based retirement plan options maintain significant investments in fossil-fuel companies, he is "...forced to either compromise his religious beliefs or forego a significant component of his employer-provided benefit." The suit claims that Hartley requested that his employer "provide him with an accommodation that would allow him to partake of the benefits of his 401(k) plan in a manner consistent with his faith" - and that he "provided Thermo Fisher with a list of several funds that are frequently available on 401(k) menus and that are consistent with his beliefs, and asked that the company make one of them (or a similar fund of the company's choosing) available on the 401(k) plan menu." The suit notes that Thermo Fisher acknowledged receipt of the accommodation request "...but, despite multiple attempts to follow up and initiate negotiations, Thermo Fisher has failed to offer any accommodation or reason why such accommodation cannot be provided". Arguing that Hartley has been "subjected to persistent discrimination and denial of reasonable accommodations due to his religion," the suit says it wants to compel Thermo Fisher to "cease its unlawful discriminatory practices, implement effective policies to prevent religious discrimination, provide reasonable accommodations as required by law, and compensate him for the damages he has suffered as a result of Thermo Fisher's actions." Stay tuned. - Nevin E. Adams, JD [i] Hartley is represented by Kathleen Konopka of ClientEarth USA Inc. [ii] Title VII defines religion to include "all aspects of religious observance and practice, as well as belief," and requires an employer to accommodate its employees' religious beliefs "unless an employer demonstrates that he is unable to reasonably accommodate an employee's or prospective employee's religious observance or practice without undue hardship on the conduct of the employer's business." [iii] The suit asserts that "Dr. Hartley believes his Christian faith commands him to care for and steward the earth, and that actively investing in and profiting from fossil fuel companies whose work directly harms the earth, and its inhabitants, violates his religious obligations." Please log in or create a free account to comment on this article. Share to: Publish date: August 05, 2026 By: Sponsored by MFS
Critical vulnerability in DNA forensic software threatens 30 years of evidence. Post Views: 14 Researchers have identified a significant security flaw in forensic software used by U.S. crime laboratories, risking DNA evidence from 1995 onward. Discovery of the vulnerability. Researchers have identified a significant security flaw in forensic software utilized by major U.S. crime laboratories, which could enable unauthorized modifications to DNA evidence dating back to 1995. The vulnerability, uncovered by a team of forensic and computer scientists, allows an AI-driven approach to alter digital representations of genetic data without detection. Impact on forensic evidence. Although the software vendor, Thermo Fisher Scientific, has not reported any confirmed breaches, the researchers emphasize that methods to detect such tampering remain elusive. A systems engineer demonstrated the exploit within an hour, gaining access to encrypted data. The potential for malicious actors to manipulate DNA profiles raises concerns about wrongful convictions or unjust acquittals. Broader implications. Experts highlight that forensic science has lagged in implementing robust security protocols compared to other sectors, resulting in inconsistent safeguards across more than 200 laboratories. Thermo Fisher Scientific has acknowledged the issue and is developing a software update incorporating digital signatures to ensure data integrity moving forward. Technical details of the exploit. The flaw specifically enables the manipulation of digital scans generated since 1995, leveraging machine learning techniques to introduce undetectable alterations. This capability could allow adversaries to introduce or remove genetic markers, undermining the reliability of forensic conclusions. Researchers noted that the exploit bypasses existing verification mechanisms, leaving no clear audit trail for investigators. Response and mitigation efforts. The discovery underscores broader challenges in securing legacy systems within the forensic sector, where rapid technological advancements have outpaced the adoption of modern cybersecurity practices. Thermo Fisher Scientific confirmed the vulnerability and stated that the upcoming update will include cryptographic validation to prevent unauthorized data modifications. However, the lack of immediate mitigation measures has prompted calls for urgent review of evidence-handling protocols. Long-Term concerns. The incident also raises questions about the long-term integrity of genetic databases, which contain records critical to both criminal investigations and civil cases. The findings align with growing concerns about the intersection of artificial intelligence and forensic science, as emerging technologies introduce new vectors for exploitation. Cybersecurity experts urge forensic institutions to prioritize proactive risk assessments and collaborate with software developers to address systemic vulnerabilities.